Ratnakar Securities

Mobile Trading
COMPANY
more from company profile
HomeMarket Info Company Profile Quarterly Results

Quarterly Results

REMEDIUM LIFECARE LTD.

NSE : NABSE : 539561ISIN CODE : INE549S01036Industry : TradingHouse : Private
BSE1.210.02 (+1.68 %)
PREV CLOSE ( ) 1.19
OPEN PRICE ( ) 1.21
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3093502
TODAY'S LOW / HIGH ( )1.21 1.21
52 WK LOW / HIGH ( ) 0.814.97
Quarters
GO
Select year  
( in Million)
Particulars
Mar 2025
Audited / UnAudited
UnAudited
Net Sales
2643.23
Total Expenditure
2647.8
PBIDT (Excl OI)
-4.57
Other Income
6.59
Operating Profit
2.02
Interest
15.93
Exceptional Items
NA
PBDT
-13.90
Depreciation
0.1
Profit Before Tax
-14.00
Tax
6.46
Provisions and contingencies
NA
Profit After Tax
-20.46
Extraordinary Items
NA
Prior Period Expenses
NA
Other Adjustments
NA
Net Profit
-20.46
Minority Interest
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
Consolidated Net Profit
-20.46
Equity Capital
403.2
Face Value (IN RS)
1
Reserves
NA
Calculated EPS
-0.05
Calculated EPS (Annualised)
-0.20
No of Public Share Holdings
398720000
% of Public Share Holdings
98.89
 
NA
PBIDTM% (Excl OI)
-0.17
PBIDTM%
0.07
PBDTM%
-0.52
PBTM%
-0.53
PATM%
-0.77
 
Notes
FAQs
079-49005200 / 01 / 02
info@ratnakarsecurities.com
Download Mobile App

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
products
about us
usefull links
news room

Ratnakar Securities Pvt. Ltd. : SEBI Registration No. of NSE, BSE : INZ000191735 | SEBI Registration No. of NSDL : IN-DP-NSDL-66-88
Ratnakar Commodities Pvt. Ltd : SEBI Registration No. of MCX : INZ000024138
Investor Grievance ID : investorgrievance@ratnakarsecurities.com
Online Dispute Resolution Portal - SMART ODR
To File A Complaint on SCORES Click Here
To Close Account, Please Click Here
For Nomination, Please Click Here
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.